Outcome of Board Meeting
Adoption of Unaudited Financial Results for the quarter and half year ended September 30, 2018 along with Limited Review Report thereon.12-11-2018
12-11-2018
Board Meeting Intimation for Board Meeting Intimation For Board Meeting For Adoption Of Unaudited Financial Results For The Quarter Ended September 30, 2018
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2018 ,inter alia, to consider and approve Board Meeting Intimation for Board Meeting For Adoption Of Unaudited Financial Results For The Quarter Ended September 30, 201801-11-2018
Compliance Certificate For The Half Year Ended September 30, 2018
Compliance Certificate For The Half Year Ended September 30, 201813-10-2018
Shareholding for the Period Ended September 30, 2018
Rubra Medicaments Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here08-10-2018
Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Abha KapoorDesignation :- Director03-10-2018
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Rubra Medicaments Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here01-10-2018
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of AGM held on September 29, 201801-10-2018
Board Meeting Intimation for Consider Shifting Of Registered Office
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/08/2018 ,inter alia, to consider and approve Shifting of Registered Office17-08-2018